Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Bipolar Article Managing the burdens of bipolar disorder Schizophrenia Article Future of schizophrenia treatment: Where do we go now? Alzheimer's Disease Article New insights into Apolipoprotein E and Alzheimer’s Disease